Arch Therapeutics To Present At The Wall Street Analyst Forum Institutional Investor Conference
2/26/2014 12:05:50 PM
WELLESLEY, MA--(Marketwired - Feb 26, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a novel product aimed at controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to announce that Company CEO, Terrence W. Norchi, MD, is scheduled to present a corporate overview at The Wall Street Analyst Forum Conference in Manhattan at The University Club of NYC on Monday, March 3rd at 12:05 PM EST.
Help employers find you! Check out all the jobs and post your resume.
comments powered by